Therapeutic Drug Monitoring of Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Patients Who Develop Gastrointestinal Graft-versus-Host Disease

Posaconazole (PCZ) is the latest triazole antifungal agent that has been approved for prophylaxis of invasive aspergillosis in high-risk immunocompromised patients, such as allogeneic hematopoietic stem cell transplantation patients, who develop graft-versus-host disease (GVHD). PCZ has high interin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tonini, J., Thiébaut, A., Jourdil, J. F., Berruyer, A. S., Bulabois, C. E., Cahn, J. Y., Stanke-Labesque, F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3457412/
https://ncbi.nlm.nih.gov/pubmed/22850515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00815-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados